Brain-computer interface technology is becoming more than a hypothetical phenomenon in China with some momentum gained in terms of research and development as well as applications, especially amid the country's latest call to support the cutting-edge sector, said government officials and industry experts during the Zhongguancun Forum that ended on Tuesday.
A potential drug successfully treats the severe form of nonalcoholic fatty liver disease in non-human primates bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests. Nonalcoholic steatohepatitis (NASH) causes scarring and inflammation in the liver and is estimated to affect up to 6.5% of the global population.
BEIJING, April 4 (Xinhua) The World Health Organization has set the theme of World Health Day on April 7, 2023 as "4 years of improving public health", and the National Health Commission has set the theme of China's propaganda as "high-quality resources sink, everyone enjoys health". The average life expectancy of Chinese increased from 35 years when the People's Republic of China was founded t
CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Researchers observed no difference in 3-month functional outcomes or mortality among patients with acute ischemic stroke who underwent early BP-lowering therapy compared with a delayed strategy, a speaker reported. The results of the CATIS-2 trial were presented at the International Stroke Conference.